{
  "ptid_time": "099_S_4086_2011-06-28",
  "img_path": "/data/qiuhui/data/adni/images/099_S_4086/2011-06-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 67,939 mm³, 44.5% above the reference mean. With a Z-score of 1.29 (90.2th percentile), this represents mild enlargement; hippocampal volume measures 6,203 mm³, 11.0% below the reference mean. With a Z-score of -0.95 (17.1th percentile), this represents normal volume ; whole brain volume measures 781,164 mm³, 24.1% below the reference mean. With a Z-score of -3.16 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 81.8 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic; Smoking. MMSE: 28.0. MoCA: 24.0. Logical Memory: 14.0. Laboratory findings: Monocytes: 0.78 (profound elevated); Monocytes: 10.40 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.15 SUVR (normal ); Amyloid beta: 925.10 pg/mL (normal ); Total tau: 105.50 pg/mL (moderate reduced); Phosphorylated tau: 8.26 pg/mL (moderate reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound whole brain atrophy (Z-score -3.16) and mild ventricular enlargement, but hippocampal volume is within normal limits (Z-score -0.95). Cognitive scores (MMSE 28, MoCA 24) are borderline for MCI, while biomarkers (Aβ normal, reduced tau) do not strongly support Alzheimer’s pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting imaging and biomarker findings despite cognitive decline)",
  "timestamp": "2025-07-26T11:05:13.483666"
}